- Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes2020 | Second Faculty of Medicine
- Laboratory Parameters Associated with Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer2022 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
- Influence of neoadjuvant achemoradiotherpy on PD-L1 expression change in rectal cancer patients2019 | First Faculty of Medicine, Central Library of Charles University
- The prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma2017 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University
- PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma2018 | Faculty of Medicine in Pilsen
- PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma2022 | First Faculty of Medicine, Faculty of Science
- A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens2020 | Publication without faculty affiliation
- Case report of a patient with generalized NSCLC with high PD-L1 expression treated with pembrolizumab2020 | Publication without faculty affiliation
- High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases2023 | First Faculty of Medicine, Third Faculty of Medicine
- Programmed death-1 (PD-1) receptor/PD-1 ligand (PD-L1) expression in fumarate hydratase-deficient renal cell carcinoma2017 | Faculty of Medicine in Pilsen
- Immunotherapy in squamous NSCLC - nivolumab clinical data, our experiences with nivolumab treatment2018 | Faculty of Medicine in Pilsen
- TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- The role of durvalumab in the treatment of stage III NSCLC2020 | First Faculty of Medicine
- Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature2020 | First Faculty of Medicine, Third Faculty of Medicine
- Programmed Cell Death Ligand 1 Expression on Immune Cells and Survival in Patients With Nonmetastatic Head and Neck Cancer: A Systematic Review and Meta-analysis2023 | Third Faculty of Medicine
- NSCLC (Non-Small Cell Lung Cancer) and kidney tumor in the elderly patient with response to chemoimmunotherapy2021 | First Faculty of Medicine
- HER-3 molecular classification, expression of PD-L1 and clinical importance in breast cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- Immunotherapy in the first line treatment of non-small cell lung cancer2020 | Faculty of Medicine in Pilsen
- First-line treatment for non-squamous NSCLC without driver mutations2022 | Third Faculty of Medicine
- Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Clinical experience with durvalumab treatment2021 | First Faculty of Medicine
- CheckMate 9LA trial: commentary and clinical case report of patient with cerebellar metastasis2023 | First Faculty of Medicine
- Predictive testing in non-small cell lung carcinoma2021 | First Faculty of Medicine, Third Faculty of Medicine
- Immunotherapy for lung cancer at the ESMO virtual congress2020 | Publication without faculty affiliation
- Pembrolizumab as a first-line therapy in spinocellular esophageal cancer2021 | First Faculty of Medicine
- Adjuvant durvalumab after successful concomitant chemoradiotherapy of non-small cell lung cancer treatment2021 | Faculty of Medicine in Pilsen
- Is anticancer immunotherapy break-trough in lung cancer therapy?2019 | First Faculty of Medicine
- Is anticancer imunotherapy break-trough in lung cancer therapy?2020 | First Faculty of Medicine